FLSM
Frazier Life Sciences Management’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4M | Sell |
474,405
-65,000
| -12% | -$2.11M | 0.62% | 33 |
|
|
2025
Q1 | $20.4M | Hold |
539,405
| – | – | 0.93% | 22 |
|
|
2024
Q4 | $44.2M | Sell |
539,405
-340,000
| -39% | -$27.8M | 1.83% | 13 |
|
|
2024
Q3 | $100M | Sell |
879,405
-160,000
| -15% | -$18.3M | 4.03% | 7 |
|
|
2024
Q2 | $78.5M | Sell |
1,039,405
-100,000
| -9% | -$7.55M | 3.67% | 10 |
|
|
2024
Q1 | $77.8M | Sell |
1,139,405
-25,000
| -2% | -$1.71M | 3.28% | 10 |
|
|
2023
Q4 | $73.1M | Hold |
1,164,405
| – | – | 3.91% | 8 |
|
|
2023
Q3 | $59.4M | Hold |
1,164,405
| – | – | 3.94% | 7 |
|
|
2023
Q2 | $58.2M | Sell |
1,164,405
-233,000
| -17% | -$11.6M | 3.47% | 10 |
|
|
2023
Q1 | $52.4M | Hold |
1,397,405
| – | – | 3.79% | 10 |
|
|
2022
Q4 | $67M | Sell |
1,397,405
-150,000
| -10% | -$7.19M | 4.17% | 11 |
|
|
2022
Q3 | $37.1M | Sell |
1,547,405
-240,000
| -13% | -$5.76M | 2.86% | 10 |
|
|
2022
Q2 | $38.9M | Sell |
1,787,405
-522,149
| -23% | -$11.4M | 3.67% | 10 |
|
|
2022
Q1 | $55.8M | Buy |
+2,309,554
| New | +$55.8M | 4.75% | 7 |
|